Awaiting product image

Article: JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

€2.42

SKU: product-article-18806 Category:

Description

JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis

Reviews

There are no reviews yet.

Be the first to review “Article: JAK2 inhibitor pacritinib significantly benefits patient reported outcomes in myelofibrosis”

Your email address will not be published. Required fields are marked *

Related products